An analysis of primary site control and late effects according to local control modality in non-metastatic Ewing sarcoma.

PURPOSE: To examine prognostic factors for primary site control and analyze late effects according to local treatment modality in non-metastatic Ewing sarcoma (ES). MATERIALS AND METHODS: From 1976 to 2001, 76 patients with localized ES and a median age of 14.5 years were seen and treated at one ins...

Descripción completa

Detalles Bibliográficos
Publicado en:Pediatric Blood & Cancer Vol. 48; no. 4; pp. 423 - 430
Autores principales: Paulino AC, Nguyen TX, Mai WY
Formato: research tables/charts Journal Article
Publicado: Wiley-Blackwell Apr2007
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=106167200&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 106167200
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        15455009
        1XL2
      jtl: Pediatric Blood & Cancer
      issn: 15455009
      maglogo: Y
    pubinfo:
      dt: Apr2007
      vid: 48
      iid: 4
      pid: 480
      pub: Wiley-Blackwell
      place: Malden, Massachusetts
    artinfo:
      ui:
        106167200
        106167200
        2009529166
        10.1002/pbc.20754
        NLM16421909
        106167200
      ppf: 423
      ppct: 7
      formats:
      tig:
        atl: An analysis of primary site control and late effects according to local control modality in non-metastatic Ewing sarcoma.
      aug:
        au:
          Paulino AC
          Nguyen TX
          Mai WY
        affil: Department of Radiology, Division of Radiation Oncology, Baylor College of Medicine and Methodist Hospital, Houston, Texas.
      sug:
        subj:
          Bone Neoplasms Therapy
          Sarcoma, Ewing's Therapy
          Adolescence
          Adult
          Aged
          Aged, 80 and Over
          Amputation
          Antineoplastic Agents, Combined Adverse Effects
          Antineoplastic Agents, Combined Therapeutic Use
          Bone Neoplasms Drug Therapy
          Bone Neoplasms Radiotherapy
          Bone Neoplasms Surgery
          Chemotherapy, Adjuvant Adverse Effects
          Child
          Child, Preschool
          Combined Modality Therapy
          Cox Proportional Hazards Model
          Female
          Iowa
          Kaplan-Meier Estimator
          Log-Rank Test
          Male
          Middle Age
          Multivariate Analysis
          Neoplasm Recurrence, Local Epidemiology
          Neoplasms, Radiation-Induced Epidemiology
          Neoplasms, Radiation-Induced Etiology
          Neoplasms, Second Primary Epidemiology
          Neoplasms, Second Primary Etiology
          Prognosis
          Radiotherapy, Adjuvant Adverse Effects
          Regression
          Sarcoma, Ewing's Drug Therapy
          Sarcoma, Ewing's Radiotherapy
          Sarcoma, Ewing's Surgery
          Survival Analysis
          Treatment Outcomes
          Human
          Adolescent: 13-18 years
          Adult: 19-44 years
          Aged: 65+ years
          Aged, 80 & over
          Child: 6-12 years
          Child, Preschool: 2-5 years
          Middle Aged: 45-64 years
          Female
          Male
      ab: PURPOSE: To examine prognostic factors for primary site control and analyze late effects according to local treatment modality in non-metastatic Ewing sarcoma (ES). MATERIALS AND METHODS: From 1976 to 2001, 76 patients with localized ES and a median age of 14.5 years were seen and treated at one institution. Tumors were located in the extremity in 38, pelvis in 13, spine in 11, trunk in 8, and head and neck in 6. Tumor size was </=8 cm in 44 and >8 cm in 32. Local therapy included radiotherapy (RT) alone in 40, surgery (S) alone in 27, and surgery followed by postoperative radiotherapy (S + RT) in 9. Chemotherapy (CT) was delivered to 65 patients (86%). Median follow-up for surviving patients was 9.7 years. RESULTS: The 5- and 10-year overall survival rates were 57.5% and 52.1% while the 5- and 10-year local control rate was 79.2%. The 5- and 10-year local control rates were 78.2% for RT, 77.6% for surgery, and 88.9% for S + RT (P = 0.68). Multivariate analysis showed that only the use of CT was found to be a prognostic factor for local control (P = 0.014). The 5- and 10-year local control rates were 83.7% for those receiving CT and 51.1% for those not receiving CT. For patients followed at least 5 years from diagnosis, late effects were seen in 10 of 19 (52.6%) receiving RT, 2 of 5 (40%) receiving S + RT, and 4 of 16 (25%) receiving surgery alone. The most common late effects with RT were muscular atrophy, limb length growth delay, and development of second malignancy. Scoliosis and decrease range of motion of an extremity were seen regardless of local treatment modality. Three patients who had surgery alone had an amputation whereas two who had RT had an amputation secondary to relapse or development of osteosarcoma. CONCLUSION: In this single institution study, the use of CT was the only factor found to impact on local control. Late effects were common regardless of local control strategy. Pediatric Blood Cancer (c) 2006 Wiley-Liss, Inc.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N